Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $5.5 million.

  • Anika Therapeutics' Other Non-Current Assets fell 5130.86% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 5130.86%. This contributed to the annual value of $5.7 million for FY2024, which is 8442.09% down from last year.
  • As of Q3 2025, Anika Therapeutics' Other Non-Current Assets stood at $5.5 million, which was down 5130.86% from $5.6 million recorded in Q2 2025.
  • Over the past 5 years, Anika Therapeutics' Other Non-Current Assets peaked at $36.3 million during Q4 2023, and registered a low of $5.5 million during Q3 2025.
  • Its 5-year average for Other Non-Current Assets is $17.0 million, with a median of $18.7 million in 2021.
  • Per our database at Business Quant, Anika Therapeutics' Other Non-Current Assets skyrocketed by 11084.27% in 2023 and then tumbled by 8442.09% in 2024.
  • Over the past 5 years, Anika Therapeutics' Other Non-Current Assets (Quarter) stood at $20.3 million in 2021, then dropped by 15.11% to $17.2 million in 2022, then soared by 110.84% to $36.3 million in 2023, then tumbled by 84.42% to $5.7 million in 2024, then fell by 2.63% to $5.5 million in 2025.
  • Its Other Non-Current Assets stands at $5.5 million for Q3 2025, versus $5.6 million for Q2 2025 and $5.7 million for Q1 2025.